bpc 157 canada BPC-157 – No Proof Required! | Office for Science and Society Buy BPC-157 - TB-500 Peptides

Q: What purity level is required for research-grade BPC-157

In clinical use, the most commonly reported side effects are: Mild injection site redness or swelling (resolves within hours) Occasional lightheadedness following injection (less common, position-dependent) Temporary nausea with oral administration in some patients Who should not use BPC-157: Patients with active cancer or a history of cancer should discuss BPC-157 carefully with their oncologist before use angiogenic peptides theoretically could support tumor vascularity, though no evidence of this has been demonstrated in animals

If they came as separate vials, treat co-injection as a compatibility decision, not an automatic rule

It's best to follow their directions and use this article as a refresher